Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
amgen
bristol-myers squibb
4
×
clinical trials
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
4
×
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
indiana blog main
indiana top stories
merck
pfizer
roche
biotech ipos
bridgebio
cancer
chinook therapeutics
duchenne muscular dystrophy
What
bio
4
×
roundup
days
drug
pricing
advanced
advantages
alliance
arrival
august
award
bar
biotech
brings
bristol
busy
buy
calls
cancer
changing
color
crispr
data
death
decades
decisions
dems
devices
drugs
expect
fda
gamble
given
growing
hours
immunotherapy
kudos
leaves
legacy
longer
Language
unset
4
×
Current search:
bio
×
photo
×
" san francisco blog main "
×
" bristol-myers squibb "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More